Novanta Inc Expected to Earn Q4 2018 Earnings of $0.51 Per Share (NOVT)

Share on StockTwits

Novanta Inc (NASDAQ:NOVT) – Analysts at William Blair issued their Q4 2018 earnings estimates for shares of Novanta in a research note issued to investors on Wednesday, January 9th. William Blair analyst B. Drab forecasts that the technology company will post earnings of $0.51 per share for the quarter.

Novanta (NASDAQ:NOVT) last posted its earnings results on Tuesday, November 6th. The technology company reported $0.61 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.52 by $0.09. Novanta had a return on equity of 18.95% and a net margin of 6.18%. The firm had revenue of $160.79 million during the quarter, compared to analyst estimates of $154.43 million. During the same period in the previous year, the company earned $0.45 EPS. The company’s revenue for the quarter was up 9.9% on a year-over-year basis.

Several other equities research analysts have also weighed in on NOVT. BidaskClub upgraded Novanta from a “hold” rating to a “buy” rating in a report on Friday, December 21st. Zacks Investment Research lowered Novanta from a “buy” rating to a “hold” rating in a report on Wednesday, October 10th. Finally, ValuEngine upgraded Novanta from a “hold” rating to a “buy” rating in a report on Wednesday, October 31st. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Novanta presently has an average rating of “Buy” and a consensus target price of $67.00.

NOVT opened at $67.45 on Friday. Novanta has a twelve month low of $48.40 and a twelve month high of $78.85. The company has a debt-to-equity ratio of 0.69, a current ratio of 2.89 and a quick ratio of 1.97. The company has a market capitalization of $2.34 billion, a P/E ratio of 33.06 and a beta of 1.55.

A number of hedge funds and other institutional investors have recently modified their holdings of NOVT. BlueMountain Capital Management LLC bought a new position in Novanta in the 3rd quarter worth approximately $110,000. Envestnet Asset Management Inc. increased its position in shares of Novanta by 58.7% during the second quarter. Envestnet Asset Management Inc. now owns 2,571 shares of the technology company’s stock valued at $160,000 after purchasing an additional 951 shares during the period. Man Group plc bought a new stake in shares of Novanta during the third quarter valued at approximately $237,000. Jefferies Group LLC bought a new stake in shares of Novanta during the third quarter valued at approximately $312,000. Finally, Jane Street Group LLC bought a new stake in shares of Novanta during the third quarter valued at approximately $363,000. 84.47% of the stock is currently owned by institutional investors.

In other Novanta news, Director Stephen W. Bershad sold 500,000 shares of Novanta stock in a transaction that occurred on Thursday, November 15th. The stock was sold at an average price of $68.15, for a total value of $34,075,000.00. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO Matthijs Glastra sold 20,000 shares of Novanta stock in a transaction that occurred on Tuesday, November 6th. The stock was sold at an average price of $74.00, for a total value of $1,480,000.00. Following the completion of the transaction, the chief executive officer now directly owns 71,107 shares in the company, valued at $5,261,918. The disclosure for this sale can be found here. Insiders own 6.70% of the company’s stock.

About Novanta

Novanta Inc, together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. The company's Photonics segment offers photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products for photonics-based applications, such as industrial material processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures.

Further Reading: How to Invest in an Index Fund

Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Ryerson Holding Corp  Expected to Announce Quarterly Sales of $1.13 Billion
Ryerson Holding Corp Expected to Announce Quarterly Sales of $1.13 Billion
Lantheus Holdings Inc  Receives Consensus Recommendation of “Buy” from Analysts
Lantheus Holdings Inc Receives Consensus Recommendation of “Buy” from Analysts
Piper Jaffray Companies Comments on Regions Financial Corp’s Q1 2019 Earnings
Piper Jaffray Companies Comments on Regions Financial Corp’s Q1 2019 Earnings
Equities Analysts Set Expectations for U.S. Bancorp’s Q1 2019 Earnings
Equities Analysts Set Expectations for U.S. Bancorp’s Q1 2019 Earnings
Simmons First National  Given a $30.00 Price Target at Stephens
Simmons First National Given a $30.00 Price Target at Stephens
Cherry Hill Mortgage Investment  Given a $20.00 Price Target at Wedbush
Cherry Hill Mortgage Investment Given a $20.00 Price Target at Wedbush


Leave a Reply

 
© 2006-2019 Zolmax.